Dimension Research is proud to have participated in an expert consultation organized by the World Health Organization (WHO), NHSRC, and DRA Pakistan. Our CEO, Khurram Zaki Khan represented DR to enhance national capacity for Randomized Controlled Trials (RCTs) and large-scale studies. He also presented the largest COVID-19 vaccine study conducted under Dimension Research’s leadership as a CRO.

The gathering included DRAP stakeholders for clinical trials, comprising professionals from CROs, clinical trial site experts, as well as representatives from DRAP and WHO. The focus was on evaluating current capacities and exploring ways to enhance the ability to conduct large-scale randomized controlled trials (RCTs).

#DimensionResearch #HealthcareInnovation #RCT #HealthExperts #GlobalHealth #ClinicalResearch